A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
Clinical trial NCT06072183 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06072183
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2027-07-30
- Enrollment
- 1571
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.